Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Semler Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554859-25-000053), on October 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.